First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):220-222. doi: 10.18176/jiaci.0839. Epub 2022 Jul 7.
No abstract available

Keywords: Asthma control; Eosinophilic asthma; Monoclonal antibodies; Reslizumab.

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma* / drug therapy
  • Eosinophils
  • Humans

Substances

  • reslizumab
  • Antibodies, Monoclonal, Humanized
  • Anti-Asthmatic Agents